We, “Disha APIs Pvt Ltd”, are recognized trading house of PHARMACEUTICAL RAW MATERIALS, BULK DRUGS & APIs. Backed by the rich guidance of our founder & mentor,MR. NIKHIL ASHRA, we have been able to provide quality products & services to our clients. Based in Ahmedabad, We have carved...
With headquarters in Hyderabad, India. Sris Synthesis offers Synthesis of organic intermediates and custom manufacturing and research. Much of our work concentrates on the manufacture of intermediates for APIs. We develop and do research of the synthesis products for both the pharmaceutical and cosmeti...
Mumbai, India | March 31, 2021: Piramal Pharma Limited’s (PPL) Contract Development and Manufacturing Organization (CDMO), Piramal Pharma Solutions (PPS), announced today that PPL has entered into an agreement to acquire a 100% stake in Hemmo Pharmaceut...
Get Catalog Details of Apis Intermediates Supplier, Manufacturer, Exporter, Dealer, Trader, Wholesaler, Companies in India
Product Name:APIs Under Development Synonyms:APIs Under Development CAS: MF: MW:0 EINECS: Mol File:Mol File Browse by Nationality Suppliers>China suppliers India (1)Member(1)All (1) EnquiryRecommend You Select Member Companies Company Name:HEMA PHARMACEUTICALS PVT LTD ...
Kotak Mahindra Capital Company Ltd served as financial advisor and Economic Laws Practice (ELP) served as legal advisors to PPL on this transaction. Torreya Partners India LLP served as financial advisor and Desai & Diwanji, Mumbai Office served as legal advisors to Hemmo Phar...
企业名称Disha APIs Pvt Ltd 地址A/817,Siddhivinayak Towers,8Th Floor,Near Kataria Arcade,Off S.G. Highway,Makarba Road,Ahmedabad – 380051 (Gujarat) India. 国家/地区印度 公司官网暂无权限 公司联系电话暂无权限 公司邮箱暂无权限 公司简介Disha APIs Pvt Ltd是公认的医药原料药、原料药和大宗药物贸易公司...
ideas and projects under one roof where they can be evaluated for their future prospective for development, scale up and commercialization. Dr. Akarsh Saxena, MD, NRST Pvt. Ltd. has also supported the project with the vision to contribute to the “Make In India” project of the government....
The Scheme has been designed with an objective to attain self-reliance and reduce import dependence in these critical bulk drugs as India country is significantly dependent on the import of basic raw materials, viz., bulk drugs that are used to produce medicines. In some specific bulk drugs, ...
Pvt. Ltd., New Delhi, India. pp. 29-32.Shivakoti, G. P. and S. Bista. 2000. Major constraints in the performance of Apis mellifera and Apis cerana under Khumaltar Conditions. In: M. Matsuka, L. R. Verma, S. Wongsiri, K. K. Shrestha and U. Partap (eds.). Asian Bees and ...